Ampion™ Reduces All-cause Mortality in COVID-19 Respiratory Distress by Nearly 80%
Ampio Pharmaceuticals, revealed positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in ...
Read moreAmpio Pharmaceuticals, revealed positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.